Home
Nath Bio-genes (india) Ltd Share Price History
Nath Bio-Genes (India) Ltd
NSE : 15 Jan, 2025
176.09-1.9 (-1.1%)
Prev Close
178.0
Open Price
173.3
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
16658
Today's High / Low
181.9 / 172.3
52 WK High / Low
264.3 / 167.1
Market Price of Nath Bio-Genes (India) Ltd
1M
1Y
3Y
5Y
Monitoring Nath Bio-Genes (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2022 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | -35.46 |
| YoY Gr. | - |
| Net Profit (Cr.) | -67 |
| BVPS | 285.16 |
Key Financial Parameters
| Parameter | 2012 |
|---|---|
| Return on Capital Emp. % | 18.67 |
| Op. Profit Mgn % | 12.57 |
| Net Profit Mgn % | 7.42 |
| Debt to Equity % | 0.24 |
Latest Shareholding
Promoters Holdings Over Time
About Nath Bio-Genes (India) Ltd
- Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
- The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.
FAQs for Nath Bio-Genes (India) Ltd Share Price History
What are the key events that typically impact Nath Bio-Genes (India) Ltd's share price history?
Key events that impact Nath Bio-Genes (India) Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Nath Bio-Genes (India) Ltd's share price history?
Stock splits reduce the nominal price of Nath Bio-Genes (India) Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Nath Bio-Genes (India) Ltd?
Dividends can influence Nath Bio-Genes (India) Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Nath Bio-Genes (India) Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Nath Bio-Genes (India) Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Nath Bio-Genes (India) Ltd’s share price history?
To understand Nath Bio-Genes (India) Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
